002737 葵花藥業
按盤價 
11.890 -1.090 (-8.398%)
11.890 -1.090 (-8.398%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.049 | -6.275 | 10.764 | 24.958 | 21.916 |
| 總資產報酬率 ROA (%) | 1.495 | -4.623 | 7.744 | 16.087 | 13.693 |
| 投入資產回報率 ROIC (%) | 1.843 | -5.766 | 10.070 | 21.737 | 18.557 | 邊際利潤分析 |
| 銷售毛利率 (%) | 54.919 | 38.152 | 44.893 | 56.291 | 57.749 |
| 營業利潤率 (%) | 6.734 | -10.837 | 18.840 | 23.978 | 21.297 |
| 息稅前利潤/營業總收入 (%) | 6.630 | -11.870 | 18.104 | 23.206 | 21.002 |
| 淨利潤/營業總收入 (%) | 5.706 | -12.816 | 14.887 | 20.436 | 17.857 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 119.489 | 96.785 | 80.634 | 88.883 | 96.075 |
| 價值變動淨收益/利潤總額(%) | 2.796 | -12.886 | 1.883 | 2.257 | -0.917 |
| 營業外收支淨額/利潤總額(%) | -1.025 | 7.363 | -0.277 | -0.890 | -0.359 | 償債能力分析 |
| 流動比率 (X) | 3.472 | 3.041 | 3.782 | 3.150 | 2.235 |
| 速動比率 (X) | 2.854 | 2.505 | 2.937 | 2.576 | 1.944 |
| 資產負債率 (%) | 23.160 | 25.104 | 21.214 | 27.278 | 36.876 |
| 帶息債務/全部投入資本 (%) | 6.083 | 5.643 | 1.924 | -0.508 | 11.146 |
| 股東權益/帶息債務 (%) | 1,477.329 | 1,594.683 | 4,866.788 | -18,419.112 | 725.122 |
| 股東權益/負債合計 (%) | 318.884 | 286.944 | 354.335 | 253.749 | 162.156 |
| 利息保障倍數 (X) | -187.881 | 68.996 | -26.468 | -41.386 | -95.903 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 6.551 | 20.958 | 14.609 | 6.894 | 12.250 |
| 存貨周轉天數 (天) | 166.477 | 186.420 | 168.347 | 108.747 | 112.202 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 31/08/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
